Below you'll find a list of all posts that have been tagged as “life sciences”
A biopharma leader partnered with Sedulo on a multi-year competitive intelligence program to connect early clinical signals with commercial strategy. The engagement delivered continuous insights across 10 rare disease areas, enabling faster decisions, earlier warnings, and confident portfolio planning.
Bringing a new therapy to market is one of the riskiest bets in pharma, nearly one in three launches falls short of expectations, while 60% underperform when multiple therapies compete in the same space. Competitive intelligence (CI) isn’t just a tactical tool, when integrated early and continuously across development, it guides trial design, shapes payer strategy, and equips commercial teams to pivot ahead of competitive threats.
Pharmaceutical launches carry far-reaching risk and opportunity, demanding strategic precision from early development through to market entry. Sedulo’s guide outlines how integrating competitive intelligence, market insights, and cross-functional alignment across four stages can help transform high stakes into sustainable success.
Facing intensifying competition in the metabolic therapeutics arena, the pharma leader needed clear foresight into biosimilar threats, innovation pipelines, and competitor launch tactics. Through early-warning monitoring, primary intelligence, and deep landscape reporting, we helped them anticipate market shifts, align internal decision-makers, and fortify their leadership ahead of emerging disruptions.
Pharmaceutical companies need more than public data to stay ahead. Learn how integrating pharmaceutical primary intelligence fills critical gaps and uncovers real-time competitive insights.
A top pharmaceutical company partnered with Sedulo Group to leverage pharma competitive intelligence and outmaneuver competitors in a high-stakes product launch.
In pharma, the competitive landscape evolves rapidly. This post outlines how strategic competitive intelligence helps life science teams anticipate market changes, monitor rivals, and inform smarter launch, pricing, and portfolio decisions.
A U.S.-based biopharmaceutical company faced competitive pressure from upcoming cardiovascular product launches and looming generic entry. Sedulo Group delivered targeted intelligence on competitor strategies, generic threats, and market vulnerabilities through a customized monitoring program. Armed with these insights, the client implemented counter-launch tactics, adjusted pricing and distribution, and protected its market position
To navigate a fast-changing chronic pain market, a leading pharma company partnered with Sedulo for targeted competitive intelligence, gaining timely insights that shaped strategy across brand, CI, and market access teams.
In unpredictable markets, resilience isn’t optional, it’s essential. This piece explores how economic and regulatory shocks test corporate strategies and why embedding agility and cross-functional coordination into CI frameworks empowers companies to weather turbulence and stay nimble.
